| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The efficacy of sulfadoxine/pyrimethamine (S/P) in treatment of uncomplicated falciparum malaria in Africa is increasingly compromised by development of resistance. The occurrence of active site mutations in the Plasmodium falciparum gene sequences coding for dihydrofolate reductase (DHFR) and dihydropteroate synthetase (DHPS) is known to confer resistance to pyrimethamine and sulfadoxine. This study investigated the occurrence of these mutations in infected blood samples taken from Ugandan children before treatment with S/P and their relationship to parasite breakthrough by day 7. The results confirm the occurrence of mutations in DHFR and DHPS that were significantly selected under S/P pressure at day 7: a combination of alleles 51-isoleucine and 108-asparagine in DHFR, and 436-serine, 437-alanine, 540-lysine and 581-alanine in DHPS, appears to play a major role in the development of in vivo resistance in P. falciparum strains against S/P. Therefore, earlier results derived from isolates from hyperendemic areas in Tanzania were confirmed by this investigation.
This article has been cited by other articles:
|
|
 |
|
  M. Mayxay, S. Nair, D. Sudimack, M. Imwong, N. Tanomsing, T. Pongvongsa, S. Phompida, R. Phetsouvanh, N. J. White, T. J. C. Anderson, et al. Combined Molecular and Clinical Assessment of Plasmodium falciparum Antimalarial Drug Resistance in the Lao People's Democratic Republic (Laos) Am J Trop Med Hyg, July 1, 2007; 77(1): 36 - 43. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. MENARD, D. DJALLE, F. YAPOU, A. MANIRAKIZA, and A. TALARMIN FREQUENCY DISTRIBUTION OF ANTIMALARIAL DRUG-RESISTANT ALLELES AMONG ISOLATES OF PLASMODIUM FALCIPARUM IN BANGUI, CENTRAL AFRICAN REPUBLIC Am J Trop Med Hyg, February 1, 2006; 74(2): 205 - 210. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. MUGITTU, M. NDEJEMBI, A. MALISA, M. LEMNGE, Z. PREMJI, A. MWITA, W. NKYA, J. KATARAIHYA, S. ABDULLA, H.-P. BECK, et al. THERAPEUTIC EFFICACY OF SULFADOXINE-PYRIMETHAMINE AND PREVALENCE OF RESISTANCE MARKERS IN TANZANIA PRIOR TO REVISION OF MALARIA TREATMENT POLICY: PLASMODIUM FALCIPARUM DIHYDROFOLATE REDUCTASE AND DIHYDROPTEROATE SYNTHASE MUTATIONS IN MONITORING IN VIVO RESISTANCE Am J Trop Med Hyg, December 1, 2004; 71(6): 696 - 702. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. L. Gatton, L. B Martin, and Q. Cheng Evolution of Resistance to Sulfadoxine-Pyrimethamine in Plasmodium falciparum Antimicrob. Agents Chemother., June 1, 2004; 48(6): 2116 - 2123. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. SYAFRUDDIN, P. B. S. ASIH, S. L. AGGARWAL, and A. H. SHANKAR FREQUENCY DISTRIBUTION OF ANTIMALARIAL DRUG-RESISTANT ALLELES AMONG ISOLATES OF PLASMODIUM FALCIPARUM IN PURWOREJO DISTRICT, CENTRAL JAVA PROVINCE, INDONESIA Am J Trop Med Hyg, December 1, 2003; 69(6): 614 - 620. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Pearce, C. Drakeley, D. Chandramohan, F. Mosha, and C. Roper Molecular Determination of Point Mutation Haplotypes in the Dihydrofolate Reductase and Dihydropteroate Synthase of Plasmodium falciparum in Three Districts of Northern Tanzania Antimicrob. Agents Chemother., April 1, 2003; 47(4): 1347 - 1354. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Kisilevsky, I. Crandall, W. A. Szarek, S. Bhat, C. Tan, L. Boudreau, and K. C. Kain Short-Chain Aliphatic Polysulfonates Inhibit the Entry of Plasmodium into Red Blood Cells Antimicrob. Agents Chemother., August 1, 2002; 46(8): 2619 - 2626. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
